MedStar Georgetown University Hospital
Radiation Oncology residency · Washington, DC · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is Georgetown University's research in radiation oncology, which the program shares with other departments and affiliated hospitals.
About Georgetown Universityinstitution-wide radiation oncology research
Radiation Oncology publications from Georgetown University and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
151
works per year
32nd of 47 radiation oncology residency programs
+28.9%
2-year growth
5th of 47 radiation oncology residency programs
25.1%
in top 10% of field (works before 2025)
13th of 47 radiation oncology residency programs
46.3%
cited above world average
14th of 47 radiation oncology residency programs
Works per year · * 2026 so far
Oncology · 616Radiology, Nuclear Medicine and Imaging · 156
Radiation Oncology research topics at Georgetown University
Papers in the window; each links to the list on OpenAlex.
Most cited at Georgetown University since 2024
All radiation oncology papers there on OpenAlex
- Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b studyJeffrey S. Weber et al. · The Lancet · 2024 · PubMed · cited 958
- The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Lisa M Force et al. · The Lancet · 2025 · PubMed · cited 498
- Analysis of Breast Cancer Mortality in the US—1975 to 2019Jennifer Lee Caswell-Jin et al. · JAMA · 2024 · PubMed · cited 290
- Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 8-year follow-up results of efficacy and safety from the phase III CheckMate 214 trialNizar M. Tannir et al. · Annals of Oncology · 2024 · PubMed · cited 236
- Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockadeBarzin Y. Nabet et al. · Cancer Cell · 2024 · PubMed · cited 196
- Efficacy of Zenocutuzumab in NRG1 Fusion–Positive CancerAlison M. Schram et al. · New England Journal of Medicine · 2025 · PubMed · cited 148
- Vaccination of Adults With Cancer: ASCO GuidelineMini Kamboj et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 143
- Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trialLuis G Paz-Ares et al. · The Lancet · 2025 · PubMed · cited 112
- Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020Katrina A.B. Goddard et al. · JAMA Oncology · 2024 · PubMed · cited 105
- Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell TherapyMetin Özdemirli et al. · New England Journal of Medicine · 2024 · PubMed · cited 105